Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

HLA-A Protein (AA 83-352) (His tag)

HLA-A Origin: Human Host: Escherichia coli (E. coli) Recombinant > 90 % WB, SDS, Imm, PC
Catalog No. ABIN7412847
  • Target See all HLA-A Proteins
    HLA-A (Major Histocompatibility Complex, Class I, A (HLA-A))
    Protein Type
    Recombinant
    Protein Characteristics
    AA 83-352
    Origin
    • 7
    • 1
    Human
    Source
    • 4
    • 1
    • 1
    • 1
    Escherichia coli (E. coli)
    Purification tag / Conjugate
    This HLA-A protein is labelled with His tag.
    Application
    Western Blotting (WB), SDS-PAGE (SDS), Immunogen (Imm), Positive Control (PC)
    Sequence
    Tyr83-Ser352
    Characteristics
    Recombinant Major Histocompatibility Complex Class I A (MHCA), Prokaryotic expression, Tyr83-Ser352, N-terminal His Tag
    Purity
    > 90 %
    Top Product
    Discover our top product HLA-A Protein
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Comment

    Isoelectric Point:5.9

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Buffer
    20 mM Tris, 150 mM NaCl, pH 8.0, containing 1 mM EDTA, 1 mM DTT, 0.01 % SKL, 5 % Trehalose and Proclin300.
    Preservative
    ProClin
    Precaution of Use
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C,-80 °C
    Storage Comment
    Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
    Expiry Date
    12 months
  • Target
    HLA-A (Major Histocompatibility Complex, Class I, A (HLA-A))
    Alternative Name
    Major Histocompatibility Complex Class I A (HLA-A Products)
    Synonyms
    HLAA Protein, major histocompatibility complex, class I, A Protein, HLA-A Protein
    Background
    HLA-A, HLAA, MHC-A, Leukocyte Antigen A, HLA class I histocompatibility antigen, A-31 alpha chain
    Molecular Weight
    34kDa
    Pathways
    TCR Signaling, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
You are here: